European Journal of Contraception and Reproductive Health Care

Papers
(The TQCC of European Journal of Contraception and Reproductive Health Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
We don´t have elements to scare women who use oral contraceptives based on nomegestrol or chlormadinone about the risk of meningioma. Let's be careful and honest!46
Retraction37
RETRACTED ARTICLE: Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial36
Statement of Retraction: Effects of the levonorgestrel-releasing intrauterine system versus the copper intrauterine device on uterine artery Doppler indices23
Statement of Retraction: Benefits of vaginal misoprostol prior to IUD insertion in women with previous caesarean delivery: a randomised controlled trial18
Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial]17
The use and access to contraception in Sweden during the COVID-19 pandemic period16
Fertility awareness and parenthood intentions among medical students in three European countries15
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain14
Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age – a systematic review14
Clinical improvement after Essure® devices removal: a systematic review13
Impact of Covid-lockdown on abortion management at a family planning in Brussels11
Modern contraceptive use among women of reproductive age in Zimbabwe: analysis of 1999–2015 Zimbabwe Demographic Health Survey10
Pooled incidence of continuation and pregnancy rates of four contraceptive methods in young women: a meta-analysis10
Pharmacist recommendations for emergency contraception in Belgium: a simulated user study10
The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain10
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction10
Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France9
Women’s autonomy and modern contraceptive use in Ghana: a secondary analysis of data from the 2014 Ghana Demographic and Health Survey8
Contraception utilization in women with pregestational diabetes8
mHealth and its application in menstrual related issues: a systematic review8
Women’s perspectives on smartphone apps for fertility tracking and predicting conception: a mixed methods study8
Satisfaction and continuation with LNG-IUS 12: findings from the real-world kyleena® satisfaction study8
The cost burden of adolescent and young adult pregnancy: real-world evidence from the Brazilian public health care system8
Menstrual pattern and contraceptive choices of Portuguese athletes7
Contraceptive use and pregnancy plans among women of reproductive age during the first Australian COVID-19 lockdown: findings from an online survey7
Dislocated intrauterine devices: clinical presentations, diagnosis and management7
Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning7
Exploring male perceptions regarding the need to engage in preconception care – a mixed-method study amongst Dutch (prospective) fathers7
How often is oral contraception used for contraception? The need of benefit’s formalisation7
Unintended pregnancy-related factors and the occurrence of offspring congenital heart disease: a multi-site case-control study in China6
Correction6
A pioneer of hormonal contraception: Joseph W. Goldzieher6
The March 2021 Italian constitutional court ruling on surrogacy: a prelude to common European legislation for the sake of reproductive health?6
Practical training of health care providers in insertion of contraceptive implants: findings from two Brazilian centres6
Statement of Retraction: “Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS”6
Minimally invasive transurethral holmium laser surgery for the management of an IUD with bladder migration6
The use of long-acting and permanent contraceptive methods (LAPMs) among women who have completed childbearing in Indonesia: does informed choice matter?6
Statement of Retraction: “Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users6
Prevention of nodules and enhancement of antibody response to genetically engineered recombinant vaccine against Human Chorionic Gonadotropin (hCG) for contraception5
The personal experience of female obstetricians and gynaecologists with contraceptive use influences the guidance and prescription of contraceptive methods: a web-survey5
The use of a pill containing ethinylestradiol-norgestimate improves female sexuality despite the decrease in circulating androgens: a pilot study5
Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives5
Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic5
Perspectives of health care providers regarding the levonorgestrel-releasing intrauterine system5
Pandemics and populations5
Single-dose pharmacokinetics and pharmacodynamics assessment of oestriol and trimegestone containing vaginal rings in healthy women with childbearing potential5
Bleeding profile satisfaction and pain and ease of placement with levonorgestrel 19.5 mg IUD: findings from the Kyleena® Satisfaction study4
The prolonged-release oral formulations: a new era in hormonal contraception technology?4
Use of contraception and attitudes towards contraceptive use in Swedish women: an internet-based nationwide survey4
An exploratory study on the association of lifestyle factors with serum etonogestrel concentrations among contraceptive implant users4
The significant influence of history of induced abortion on the utilisation of long-acting reversible contraceptive methods in the immediate post abortion period, Northern Ethiopia4
Overnight pain and opioid use after osmotic cervical dilator placement for second trimester dilation and evacuation4
Comparison of contraceptive sales before and during the COVID-19 pandemic in Brazil4
Impact of a post-partum family planning intervention on contraception and fertility in Tanzania: two-year follow-up of a cluster-randomised controlled trial4
Exploring technology-based interventions to improve oral contraceptive pill adherence: a cross-sectional survey4
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition4
Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort4
The global pandemic and changes in women’s reproductive health: an observational study4
Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial throm4
Frequency and experience in the use of menstrual cycle monitoring applications by Brazilian women3
The use of a pill containing ethinylestradiol-norgestimate improves female sexuality despite the decrease in circulating androgen: Correspondence3
Contraception use and attitudes: women’s concerns regarding hormonal contraception and copper intrauterine devices3
Factors influencing contraception choice and use globally: a synthesis of systematic reviews3
Statement of Retraction [Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomized control trial]3
Vaginal dinoprostone versus placebo for pain relief during intrauterine device insertion: a systematic review and meta-analysis of randomised controlled trials3
Preabortion ultrasound – a patient perspective3
Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations3
Tips and tricks for the management of contraceptive etonogestrel implant in clinical practice: an Expert Opinion3
Statement of Retraction [Lidocaine gel vs lidocaine spray in reducing pain during insertion of the intrauterine contraceptive device]3
The demand for family planning to limit childbearing satisfied with female permanent contraception in Sub-Saharan Africa: a meta-analysis of demographic and health surveys3
The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women3
Migration and newborn screening: time to build on the European Asylum, Integration and Migration Fund?3
Health benefits of combined oral contraceptives – a narrative review3
Pain relief during intrauterine device placement in nulligravid women with both oral ketorolac and an analgesic: a double-blinded randomised trial3
RETRACTED ARTICLE: Effects of the levonorgestrel-releasing intrauterine system versus the copper intrauterine device on uterine artery Doppler indices3
Let’s reconsider modern progestin-only pills during isotretinoin and retinoid therapy3
0.061220169067383